Provided is a photocurable composition that contains a polymerizable monomer (A), a spherical filler (B) having an average particle size within the range of 230-1000 nm, and a polymerization initiator (C), the photocurable composition being such that: 90% or more of the individual particles that constitute the spherical filler (B) are within a range of ±5% of the average particle size; the polymerizable monomer (A) and the spherical filler (B) satisfy condition (X1) represented by formula (1): nP<nF (where nP represents the refractive index at 25° C. of a polymer obtained by polymerizing the polymerizable monomer (A), and nF represents the refractive index at 25° C. of the spherical filler (B)); and the polymerization initiator (C) includes a photosensitizing compound (C1), a tertiary amine compound (C2), and a photoacid generator (C3).

The present disclosure relates to a medical cement composition containing calcium silicate in an amount of less than 20 wt % of a total weight of the composition, with a lithium salt being added thereto. The medical cement composition of the present disclosure has a low compressive strength of 12 MPa or less, after being hardened, for easy removal, excellent stability in storage, and high bioactivity.

A biomimetic composite material includes a bioactive cement material, an autologous dentin matrix, and an inorganic nano-reinforcement material. A dental implant includes a body including a biomimetic composite material, wherein the biomimetic composite material includes a bioactive cement material, an autologous dentin matrix, and an inorganic nano-reinforcement material.

A biomimetic composite material includes a bioactive cement material, an autologous dentin matrix, and an inorganic nano-reinforcement material. A dental implant includes a body including a biomimetic composite material, wherein the biomimetic composite material includes a bioactive cement material, an autologous dentin matrix, and an inorganic nano-reinforcement material.

A biocompatible composite material for controlled release is disclosed, comprising a biocompatible metal oxide structure with a loaded network of pores. The pore network of the biocompatible composite material is filled with a uniformly distributed biologically active micellizing amphiphilic molecule, the size of these pores ranging from about 0.5 to about 100 nanometers. The material is characterized in that when exposed to phosphate-buffered saline (PBS), the controlled release of the active amphiphilic molecule is predominantly diffusion-driven over time.

A biocompatible composite material for controlled release is disclosed, comprising a biocompatible metal oxide structure with a loaded network of pores. The pore network of the biocompatible composite material is filled with a uniformly distributed biologically active micellizing amphiphilic molecule, the size of these pores ranging from about 0.5 to about 100 nanometers. The material is characterized in that when exposed to phosphate-buffered saline (PBS), the controlled release of the active amphiphilic molecule is predominantly diffusion-driven over time.

A pre-mixed strontium silicate-based biological hydraulic cement paste composition and preparation method and use thereof are disclosed. The pre-mixed strontium silicate-based biological hydraulic cement paste of the disclosure uses strontium silicate as the main phase and at least one non-aqueous solvent that is miscible with water, and preferably, it may further include at least one calcium phosphate compound and at least one radiopaque material, to prepare a biological hydraulic cement paste with excellent injectability. The material remains as a fluid under a sealed condition, and hydrates, solidifies and hardens when it is placed in a physiological environment and contacts with a physiological body fluid. The strontium silicate-based material having excellent biocompatibility and biological activity is used to prepare a pre-mixed strontium silicate-based cement paste, which can be used for medical and dental applications including fields of pulp capping, root canal therapy, dental restorations and the like.

A pre-mixed strontium silicate-based biological hydraulic cement paste composition and preparation method and use thereof are disclosed. The pre-mixed strontium silicate-based biological hydraulic cement paste of the disclosure uses strontium silicate as the main phase and at least one non-aqueous solvent that is miscible with water, and preferably, it may further include at least one calcium phosphate compound and at least one radiopaque material, to prepare a biological hydraulic cement paste with excellent injectability. The material remains as a fluid under a sealed condition, and hydrates, solidifies and hardens when it is placed in a physiological environment and contacts with a physiological body fluid. The strontium silicate-based material having excellent biocompatibility and biological activity is used to prepare a pre-mixed strontium silicate-based cement paste, which can be used for medical and dental applications including fields of pulp capping, root canal therapy, dental restorations and the like.

The present disclosure provides an inorganic dental filler including a surface treated with at least one silane. Exemplary silanes described in the present disclosure for the surface treatment of the inorganic filler include silanes of Formula I and/or Formula II: (R.sup.Si)—(CR.sup.1R.sup.2).sub.n—(NH—C(O)—O—CH.sub.2—CH.sub.2).sub.q—N(R.sup.5)—C(O)—NH—(CH.sub.2—CH.sub.2—O).sub.t—CR.sup.3R.sup.4—CH.sub.2-(A) Formula I (R.sup.Si)—(CR.sup.1R.sup.2).sub.n—NH—C(O)—O—CR.sup.3R.sup.4-(L).sub.q-CH.sub.2-(A) Formula II, wherein: R.sup.Si is a silane-containing group of the formula —Si(Y.sub.p)(R.sup.6).sub.3-p, wherein Y is a hydrolysable group, R.sup.6 is a monovalent alkyl or aryl group, and p is 1, 2, or 3. Methods of making and using the surface treated inorganic dental fillers are also disclosed.

The present disclosure provides an inorganic dental filler including a surface treated with at least one silane. Exemplary silanes described in the present disclosure for the surface treatment of the inorganic filler include silanes of Formula I and/or Formula II: (R.sup.Si)—(CR.sup.1R.sup.2).sub.n—(NH—C(O)—O—CH.sub.2—CH.sub.2).sub.q—N(R.sup.5)—C(O)—NH—(CH.sub.2—CH.sub.2—O).sub.t—CR.sup.3R.sup.4—CH.sub.2-(A) Formula I (R.sup.Si)—(CR.sup.1R.sup.2).sub.n—NH—C(O)—O—CR.sup.3R.sup.4-(L).sub.q-CH.sub.2-(A) Formula II, wherein: R.sup.Si is a silane-containing group of the formula —Si(Y.sub.p)(R.sup.6).sub.3-p, wherein Y is a hydrolysable group, R.sup.6 is a monovalent alkyl or aryl group, and p is 1, 2, or 3. Methods of making and using the surface treated inorganic dental fillers are also disclosed.